| Publisher: American Medical Association
| ||||||||||||||||||||||||||||||
Similar Journals
|
JAMA Otolaryngology - Head & Neck Surgery
Journal Prestige (SJR): 1.462  Citation Impact (citeScore): 2 Number of Followers: 35  Subscription journalISSN (Print) 2168-6181 - ISSN (Online) 2168-619X Published by American Medical Association  [14 journals]
|
- JAMA Otolaryngology–Head & Neck Surgery
-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Pages: 952 - 952
Abstract: Mission Statement: JAMA Otolaryngology–Head & Neck Surgery provides timely information for physicians and scientists concerned with diseases of the head and neck. Given the diversity of structure and function based in this anatomic region, JAMA Otolaryngology–Head & Neck Surgery publishes clinical, translational, and population health research from an array of disciplines. We place a high priority on strong study designs that accurately identify etiologies, evaluate diagnostic strategies, and distinguish among treatment options and outcomes. Our objectives are to (1) publish original contributions that will enhance the clinician’s understanding of otolaryngologic disorders, benefit the care of our patients, and stimulate research in our field; (2) forecast important advances within otolaryngology–head and neck surgery, particularly as they relate to the prevention, diagnosis, and treatment of disease through clinical and translational research, including that of the human genome and novel imaging techniques; (3) address questions of clinical outcomes and cost-effectiveness that result from clinical intervention, which grow in importance as health care providers are increasingly challenged to provide evidence of enhanced survival and quality of life; (4) provide expert reviews of topics that keep our readers current with true advances and also to provide a valuable educational resource for trainees in the several disciplines that treat patients with diseases of the head and neck; (5) serve as a forum for the concerns of otolaryngologists, such as socioeconomic, legal, ethical, and medical issues; (6) provide helpful critiques that enable contributing authors to improve their submissions. We encourage a concise presentation of information and employ an abstract format that efficiently assesses validity and relevance from a clinical perspective. This approach promotes succinct yet complete presentation for our readers and electronic information resources. We believe this approach typifies the commitment of JAMA Otolaryngology–Head & Neck Surgery to providing important information that is easily interpreted by its diverse readership.
PubDate: Wed, 01 Nov 2023 00:00:00 GMT
DOI: 10.1001/jamaoto.2022.3151
Issue No: Vol. 149, No. 11 (2023)
-
- The Call to Joyful Sacrificial Giving
-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Pages: 953 - 954
Abstract: This Viewpoint explores the role of the servant leader and its implications as a leadership model for head and neck surgeons.
PubDate: Wed, 01 Nov 2023 00:00:00 GMT
DOI: 10.1001/jamaoto.2023.2716
Issue No: Vol. 149, No. 11 (2023)
-
- Core Biopsy and Extranodal Extension in Surgically Treated HPV-Associated
Oropharyngeal Squamous Cell Carcinoma-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Pages: 955 - 960
Abstract: This cohort study assesses whether preoperative nodal core needle biopsy is associated with presence of extranodal extension in final pathology findings among patients with human papillomavirus (HPV)–associated oropharyngeal squamous cell carcinoma targeted for primary surgical resection.
PubDate: Wed, 01 Nov 2023 00:00:00 GMT
DOI: 10.1001/jamaoto.2023.1897
Issue No: Vol. 149, No. 11 (2023)
-
- Oncologic Significance of Therapeutic Delays in Oral Cavity Cancer
-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Pages: 961 - 969
Abstract: This cohort study reports treatment delays for patients with oral cavity cancer in Canada and evaluates the outcome of treatment delays on overall survival.
PubDate: Wed, 01 Nov 2023 00:00:00 GMT
DOI: 10.1001/jamaoto.2023.1936
Issue No: Vol. 149, No. 11 (2023)
-
- Treatment Delays in Oral Cavity Cancer
-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Pages: 969 - 970
Abstract: Timeliness and multidisciplinary coordination have long been recognized as 2 hallmarks of quality cancer care. These quality pillars are especially relevant in the treatment of locally advanced head and neck cancer (HNC), which is founded on precise patient-centered coordination of a multiteam system (eg, interdependent teams of surgical, radiation, and medical oncology teams). Recognizing the importance of timely, coordinated multidisciplinary care in improving outcomes and equity in patients with HNC, the American College of Surgeons/Commission on Cancer selected initiation of adjuvant radiation therapy within 6 weeks of surgery as its first-ever quality metric for HNC. This metric aligns HNC with other disease sites (eg, breast, colon, lung) that also measure quality in terms of timely, coordinated multidisciplinary adjuvant therapy, recognizes the recommendation by the National Comprehensive Cancer Network guidelines that postoperative radiation therapy (PORT) start within 6 weeks of surgery for HNC, and highlights the well-characterized quality gap in this space. This metric is at present generalized to all postoperative settings and remains informational in nature, and it will necessarily be adapted to the subtleties and complexities of practice as more discriminating clinical data are obtained.
PubDate: Wed, 01 Nov 2023 00:00:00 GMT
DOI: 10.1001/jamaoto.2023.1942
Issue No: Vol. 149, No. 11 (2023)
-
- Performance of Liquid Biopsy for Diagnosis and Surveillance of
HPV-Associated Oropharyngeal Cancer-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Pages: 971 - 977
Abstract: This cohort study aims to establish the clinical efficacy of plasma tumor tissue–modified human papillomavirus DNA testing in the diagnosis and surveillance of human papillomavirus–associated oropharyngeal squamous cell carcinoma in a contemporary clinical setting.
PubDate: Wed, 01 Nov 2023 00:00:00 GMT
DOI: 10.1001/jamaoto.2023.1937
Issue No: Vol. 149, No. 11 (2023)
-
- Circulating Human Papillomavirus Tumor DNA—Ready for Prime Time'
-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Pages: 978 - 979
Abstract: The detection of cell-free tumor DNA fragments shed into the circulation, reflecting the mutational landscape of a tumor type, has transformed the management of many cancers but not head and neck cancer. In contrast with other head and neck carcinomas, human papillomavirus (HPV)-associated oropharynx cancer has a unique and pervasive molecular signature that would make it an ideal candidate for detection and surveillance of HPV-mediated disease. Recent advances in the technology have enabled the sensitive and reliable identification and quantification of low copy number HPV gene expression in the blood. The clinical assay used in initial studies served as the platform for the commercially available NavDx test (Naveris), a blood test, or liquid biopsy, of circulating HPV tumor DNA.
PubDate: Wed, 01 Nov 2023 00:00:00 GMT
DOI: 10.1001/jamaoto.2023.1938
Issue No: Vol. 149, No. 11 (2023)
-
- Surgery vs Chemoradiation Outcomes in Patients With T1-T2 Oropharyngeal
Squamous Cell Carcinoma-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Pages: 980 - 986
Abstract: This national multicenter cohort study of patients with T1-T2 oropharyngeal squamous cell carcinoma compares the functional and survival outcomes of primary transoral robotic surgery vs primary radiation therapy and/or chemoradiation.
PubDate: Wed, 01 Nov 2023 00:00:00 GMT
DOI: 10.1001/jamaoto.2023.1944
Issue No: Vol. 149, No. 11 (2023)
-
- Demographic and Academic Productivity Among AHNS Fellows Over 20 Years
-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Pages: 987 - 992
Abstract: This cross-sectional study assesses demographic trends and academic productivity among American Head & Neck Society fellowship graduates.
PubDate: Wed, 01 Nov 2023 00:00:00 GMT
DOI: 10.1001/jamaoto.2023.2021
Issue No: Vol. 149, No. 11 (2023)
-
- Personalized Oral Cancer Survival Calculator to Estimate Risk of Death
From Oral Cancer or Other Causes-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Pages: 993 - 1000
Abstract: This decision analytical model study of US adults with oral cancer uses health records linked with Medicare files to model an oral cancer survival calculator accounting for other health-related causes of death.
PubDate: Wed, 01 Nov 2023 00:00:00 GMT
DOI: 10.1001/jamaoto.2023.1975
Issue No: Vol. 149, No. 11 (2023)
-
- Novel Oral Cancer Survival Calculator—Do We Have a Crystal Ball'
-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Pages: 1000 - 1002
Abstract: With a new diagnosis of head and neck cancer, the foremost priority for patients is survival. Naturally, patients wrestle with treatment options, the implications on survival outcomes, and adverse effects. To guide these crucial conversations, in this issue of JAMA Otolaryngology–Head & Neck Surgery, Davies et al present a predictive model for oral cavity squamous cell cancer (OCC) that seeks to provide a “holistic and personalized” estimate of survival that incorporates general health status and competing causes of death. The calculator accounts for patients’ variable and often low literacy of survival curves and permits patients to choose how to view their chance of surviving or dying of OCC or other causes by line graph, pie chart, or people charts at 1, 5, and 9 years after diagnosis. In addition to infographics that translate percentages, the calculator offers explanations with literacy levels that are directed at patients, not physicians. This calculator can potentially bridge the gaps between the survival estimates in the literature, life tables, clinical gestalt, and physician attempts to contextualize the inherent limitations of applying survival curves and averages to the 1 patient with the diagnosis.
PubDate: Wed, 01 Nov 2023 00:00:00 GMT
DOI: 10.1001/jamaoto.2023.1976
Issue No: Vol. 149, No. 11 (2023)
-
- Selective Deep Lobe Parotidectomy vs Total Parotidectomy for Benign Deep
Lobe Parotid Tumors-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Pages: 1003 - 1010
Abstract: This case series compares selective deep lobe parotidectomy vs total parotidectomy for patients with benign tumors in the deep lobe for postoperative complications and tumor control and recurrence.
PubDate: Wed, 01 Nov 2023 00:00:00 GMT
DOI: 10.1001/jamaoto.2023.2981
Issue No: Vol. 149, No. 11 (2023)
-
- Margin Assessment Methods and Recurrence in Oral Cavity Squamous Cell
Carcinoma-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Pages: 1011 - 1020
Abstract: This retrospective study of margin assessment methods after oral cavity squamous cell carcinoma resection compares tumor bed vs resection specimen sampling and the risk of recurrence.
PubDate: Wed, 01 Nov 2023 00:00:00 GMT
DOI: 10.1001/jamaoto.2023.2982
Issue No: Vol. 149, No. 11 (2023)
-
- Team-Based Surgical Approach to Head and Neck Microvascular Free Flap
Reconstruction-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Pages: 1021 - 1026
Abstract: This cohort study investigates the association of team-based surgical approaches with intraoperative and postoperative outcomes for patients undergoing head and neck free flap reconstruction.
PubDate: Wed, 01 Nov 2023 00:00:00 GMT
DOI: 10.1001/jamaoto.2023.3028
Issue No: Vol. 149, No. 11 (2023)
-
- Outcome in Advanced OSCC After Refusal of Recommended Adjuvant Therapy
-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Pages: 1027 - 1033
Abstract: This cohort study evaluates survival and recurrence for patients with and without recommended adjuvant therapy after resection of advanced oral squamous cell carcinoma.
PubDate: Wed, 01 Nov 2023 00:00:00 GMT
DOI: 10.1001/jamaoto.2023.3111
Issue No: Vol. 149, No. 11 (2023)
-
- Risk of Carcinoma in Pleomorphic Adenomas of the Parotid
-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Pages: 1034 - 1041
Abstract: This cohort study examined the rate of carcinoma ex pleomorphic adenoma (CXPA) detection in untreated pleomorphic adenomas of the parotid gland and factors associated with development of CXPA.
PubDate: Wed, 01 Nov 2023 00:00:00 GMT
DOI: 10.1001/jamaoto.2023.3212
Issue No: Vol. 149, No. 11 (2023)
-
- Key Points for Clinicians About the SEER Oral Cancer Survival Calculator
-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Pages: 1042 - 1046
Abstract: This Special Communication describes a calculator that is designed to provide patient-specific survival estimates based on the severity of an index cancer as well as the competing risk of death of other comorbid ailments.
PubDate: Wed, 01 Nov 2023 00:00:00 GMT
DOI: 10.1001/jamaoto.2023.1977
Issue No: Vol. 149, No. 11 (2023)
-
- Methods and Outcomes of Screening for Head and Neck Cancers
-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Pages: 1047 - 1056
Abstract: This systematic review assesses methods and detection rates of head and neck cancer screening and patient survival in studies conducted from 2001 to 2022.
PubDate: Wed, 01 Nov 2023 00:00:00 GMT
DOI: 10.1001/jamaoto.2023.3010
Issue No: Vol. 149, No. 11 (2023)
-
